296 related articles for article (PubMed ID: 30009527)
1. Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer.
Hartana CA; Ahlén Bergman E; Broomé A; Berglund S; Johansson M; Alamdari F; Jakubczyk T; Huge Y; Aljabery F; Palmqvist K; Holmström B; Glise H; Riklund K; Sherif A; Winqvist O
Clin Exp Immunol; 2018 Oct; 194(1):39-53. PubMed ID: 30009527
[TBL] [Abstract][Full Text] [Related]
2. Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathway.
Hartana CA; Ahlén Bergman E; Zirakzadeh AA; Krantz D; Winerdal ME; Winerdal M; Johansson M; Alamdari F; Jakubczyk T; Glise H; Riklund K; Sherif A; Winqvist O
PLoS One; 2018; 13(7):e0200079. PubMed ID: 29966014
[TBL] [Abstract][Full Text] [Related]
3. Skin resident memory CD8
Seidel JA; Vukmanovic-Stejic M; Muller-Durovic B; Patel N; Fuentes-Duculan J; Henson SM; Krueger JG; Rustin MHA; Nestle FO; Lacy KE; Akbar AN
Clin Exp Immunol; 2018 Oct; 194(1):79-92. PubMed ID: 30030847
[TBL] [Abstract][Full Text] [Related]
4. Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma.
Cheng Y; Gunasegaran B; Singh HD; Dutertre CA; Loh CY; Lim JQ; Crawford JC; Lee HK; Zhang X; Lee B; Becht E; Lim WJ; Yeong J; Chan CY; Chung A; Goh BKP; Chow PKH; Chan JKY; Ginhoux F; Tai D; Chen J; Lim SG; Zhai W; Choo SP; Newell EW
Immunity; 2021 Aug; 54(8):1825-1840.e7. PubMed ID: 34270940
[TBL] [Abstract][Full Text] [Related]
5. CD49a Expression Defines Tissue-Resident CD8
Cheuk S; Schlums H; Gallais Sérézal I; Martini E; Chiang SC; Marquardt N; Gibbs A; Detlofsson E; Introini A; Forkel M; Höög C; Tjernlund A; Michaëlsson J; Folkersen L; Mjösberg J; Blomqvist L; Ehrström M; Ståhle M; Bryceson YT; Eidsmo L
Immunity; 2017 Feb; 46(2):287-300. PubMed ID: 28214226
[TBL] [Abstract][Full Text] [Related]
6. Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8
Enamorado M; Iborra S; Priego E; Cueto FJ; Quintana JA; Martínez-Cano S; Mejías-Pérez E; Esteban M; Melero I; Hidalgo A; Sancho D
Nat Commun; 2017 Jul; 8():16073. PubMed ID: 28714465
[TBL] [Abstract][Full Text] [Related]
7. The Potential of Tissue-Resident Memory T Cells for Adoptive Immunotherapy against Cancer.
Beumer-Chuwonpad A; Taggenbrock RLRE; Ngo TA; van Gisbergen KPJM
Cells; 2021 Aug; 10(9):. PubMed ID: 34571883
[TBL] [Abstract][Full Text] [Related]
8. PD-1 and TIGIT coexpressing CD8 + CD103 + tissue-resident memory cells in endometrial cancer as potential targets for immunotherapy.
Jiang F; Mao M; Jiang S; Jiao Y; Cao D; Xiang Y
Int Immunopharmacol; 2024 Jan; 127():111381. PubMed ID: 38150880
[TBL] [Abstract][Full Text] [Related]
9. Cancer-specific tissue-resident memory T-cells express ZNF683 in colorectal cancer.
Kitakaze M; Uemura M; Hara T; Chijimatsu R; Motooka D; Hirai T; Konno M; Okuzaki D; Sekido Y; Hata T; Ogino T; Takahashi H; Miyoshi N; Ofusa K; Mizushima T; Eguchi H; Doki Y; Ishii H
Br J Cancer; 2023 May; 128(10):1828-1837. PubMed ID: 36869093
[TBL] [Abstract][Full Text] [Related]
10. Tissue-resident memory T cells in the skin.
Khalil S; Bardawil T; Kurban M; Abbas O
Inflamm Res; 2020 Mar; 69(3):245-254. PubMed ID: 31989191
[TBL] [Abstract][Full Text] [Related]
11. T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate.
Mackay LK; Wynne-Jones E; Freestone D; Pellicci DG; Mielke LA; Newman DM; Braun A; Masson F; Kallies A; Belz GT; Carbone FR
Immunity; 2015 Dec; 43(6):1101-11. PubMed ID: 26682984
[TBL] [Abstract][Full Text] [Related]
12. Tissue-resident memory CD8
Wang T; Shen Y; Luyten S; Yang Y; Jiang X
Pharmacol Res; 2020 Sep; 159():104876. PubMed ID: 32422340
[TBL] [Abstract][Full Text] [Related]
13. Tissue-resident memory T cells in breast cancer control and immunotherapy responses.
Byrne A; Savas P; Sant S; Li R; Virassamy B; Luen SJ; Beavis PA; Mackay LK; Neeson PJ; Loi S
Nat Rev Clin Oncol; 2020 Jun; 17(6):341-348. PubMed ID: 32112054
[TBL] [Abstract][Full Text] [Related]
14. PD-1
Wang Z; Wang S; Goplen NP; Li C; Cheon IS; Dai Q; Huang S; Shan J; Ma C; Ye Z; Xiang M; Limper AH; Porquera EC; Kohlmeier JE; Kaplan MH; Zhang N; Johnson AJ; Vassallo R; Sun J
Sci Immunol; 2019 Jun; 4(36):. PubMed ID: 31201259
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory checkpoint receptors control CD8
Gamradt P; Laoubi L; Nosbaum A; Mutez V; Lenief V; Grande S; Redoulès D; Schmitt AM; Nicolas JF; Vocanson M
J Allergy Clin Immunol; 2019 Jun; 143(6):2147-2157.e9. PubMed ID: 30654051
[TBL] [Abstract][Full Text] [Related]
16. CD8
Holz LE; Prier JE; Freestone D; Steiner TM; English K; Johnson DN; Mollard V; Cozijnsen A; Davey GM; Godfrey DI; Yui K; Mackay LK; Lahoud MH; Caminschi I; McFadden GI; Bertolino P; Fernandez-Ruiz D; Heath WR
Cell Rep; 2018 Oct; 25(1):68-79.e4. PubMed ID: 30282039
[TBL] [Abstract][Full Text] [Related]
17. CD103
Jin K; Yu Y; Zeng H; Liu Z; You R; Zhang H; Liu C; Su X; Yan S; Chang Y; Xu L; Xu J; Zhu Y; Wang Z
Br J Cancer; 2022 Jun; 126(11):1581-1588. PubMed ID: 35165401
[TBL] [Abstract][Full Text] [Related]
18. Front-Line Memory T Cells Think Outside the T-box… Mostly.
Snyder CM
Immunity; 2015 Dec; 43(6):1030-2. PubMed ID: 26682977
[TBL] [Abstract][Full Text] [Related]
19. Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment.
Pizzolla A; Keam SP; Vergara IA; Caramia F; Thio N; Wang M; Kocovski N; Tantalo D; Jabbari J; Au-Yeung G; Sandhu S; Gyorki DE; Weppler A; Perdicchio M; McArthur GA; Papenfuss AT; Neeson PJ
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35550554
[TBL] [Abstract][Full Text] [Related]
20. IL-15-Independent Maintenance of Tissue-Resident and Boosted Effector Memory CD8 T Cells.
Schenkel JM; Fraser KA; Casey KA; Beura LK; Pauken KE; Vezys V; Masopust D
J Immunol; 2016 May; 196(9):3920-6. PubMed ID: 27001957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
